^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
VENTANA pan-TRK (EPR17341) Assay

Company:
Roche
Type:
CE Marked
Related tests:

Details

Evidence
VENTANA pan-TRK (EPR17341) Assay is intended for the immunohistochemical detection of the C-terminal region of the tropomyosin receptor kinase (TRK) proteins A, B and C, which is known to be conserved across wild-type and fusion proteins, in formalin-fixed, paraffin-embedded (FFPE) neoplastic tissues stained with BenchMark IHC/ISH instruments.
Cancer:
Non Small Cell Lung Cancer, Solid Tumor
Gene:
NTRK (Neurotrophic receptor tyrosine kinase), NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1), NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2), NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3)
Method:
Immunohistochemistry (IHC)
Approvals
Date
Cancer
Gene
Drug
By
11/27/18
CE